NCT06738472

Brief Summary

This interventional study aimed to evaluate the effects of home exercise in addition to pharmacological treatment on pain threshold and spinal mobility in fibromyalgia patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 17, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

January 25, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2025

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2025

Completed
Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

11 months

First QC Date

December 13, 2024

Last Update Submit

January 20, 2026

Conditions

Keywords

fibromyalgiahome-based therapypainquality of life

Outcome Measures

Primary Outcomes (2)

  • Algometry

    pain pressure threshold

    4 weeks

  • Spinal mouse for spinal mobility

    spinal range of motion

    4 weeks

Secondary Outcomes (3)

  • Hospital Anxiety and Depression Scale (HADS)

    4 weeks

  • Pittsburgh Sleep Quality Index (PSQI)

    4 weeks

  • Short form-12 (SF-12)

    4 weeks

Study Arms (2)

Duloxetin+home based therapy

EXPERIMENTAL

Participants in this arm will receive standard pharmacological treatment for fibromyalgia as prescribed by a physician, in addition to a structured home exercise program. The home exercise program will include stretching and strengthening exercises targeting the spinal and trunk muscles and will be performed according to the study protocol. Clinical outcomes and spinal posture and mobility will be assessed using the Spinal Mouse® device in upright standing, maximum trunk flexion, and maximum trunk extension positions at baseline and follow-up.

Other: home based exercises

Duloxetin only

NO INTERVENTION

Participants in this arm will receive standard pharmacological treatment for fibromyalgia as prescribed by a physician, without any additional exercise intervention. Clinical outcomes and spinal posture and mobility will be assessed using the Spinal Mouse® device in upright standing, maximum trunk flexion, and maximum trunk extension positions at baseline and follow-up.

Interventions

given exercises to the participants

Duloxetin+home based therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants were between the ages of 18 and 65,
  • No diagnosis of rheumatic disease,
  • No diagnosis of chronic comorbid disease,
  • Participants diagnosed with fibromyalgia syndrome according to the European League Against Rheumatism (EULAR) criteria will be included as volunteers.

You may not qualify if:

  • Patients under 18, over 65 years of age
  • Those diagnosed with chronic comorbid diseases
  • Those with a history of rheumatic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahi Evran University

Kırşehir, Turkey (Türkiye)

Location

Related Publications (1)

  • Ozcelep OF, Ustun I, Algun ZC. Effect of task-oriented training on pain, functionality, and quality of life in rheumatoid arthritis. Turk J Phys Med Rehabil. 2022 Mar 1;68(1):76-83. doi: 10.5606/tftrd.2022.6666. eCollection 2022 Mar.

MeSH Terms

Conditions

FibromyalgiaPain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

December 13, 2024

First Posted

December 17, 2024

Study Start

January 25, 2025

Primary Completion

December 25, 2025

Study Completion

December 28, 2025

Last Updated

January 22, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations